ReVivo Medical Raises $2 Million for FDA Sanctioned Clinical Trial

ReVivo Medical Spinal Plates

ReVivo Medical completed its most recent equity offering.

“Since last fall we have now raised $2 million which will allow us to complete the planned 50 surgical procedures of our clinical trial,” said Gary Mittleman, President and CEO. “Raising funds is never an easy task and we are grateful to the support of the 57 angel investors who...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us